Invention Grant
- Patent Title: Riboswitch modulated gene therapy for retinal diseases
-
Application No.: US16492878Application Date: 2018-03-09
-
Publication No.: US12012602B2Publication Date: 2024-06-18
- Inventor: Daniel M. Lipinski , Chris A. Reid
- Applicant: THE MEDICAL COLLEGE OF WISCONSIN, INC.
- Applicant Address: US WI Milwaukee
- Assignee: The Medical College of Wisconsin, Inc.
- Current Assignee: The Medical College of Wisconsin, Inc.
- Current Assignee Address: US WI Milwaukee
- Agency: Quarles & Brady LLP
- International Application: PCT/US2018/021719 2018.03.09
- International Announcement: WO2018/165536A 2018.09.13
- Date entered country: 2019-09-10
- Main IPC: C12N15/115
- IPC: C12N15/115 ; A61K48/00 ; C12N15/67
Abstract:
The present invention provides constructs comprising modified riboswitches to regulate expression of a transgene within a subject. Methods of treating a disease, specifically an eye disease, are also contemplated.
Public/Granted literature
- US20200063137A1 RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES Public/Granted day:2020-02-27
Information query
IPC分类:
